This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (4)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Dr Pradhan and colleagues¹ found that elevated levels of interleukin 6 (IL-6) were associated with the risk of developing type 2 diabetes mellitus in a large cohort of apparently healthy middle-aged women. Their data are consistent with the results of others.^2-3 According to Pradhan et al, type 2 diabetes mellitus may be a manifestation of a long lasting and ongoing cytokine-mediated acute phase response involving IL-6. However, the mechanisms of the diabetogenic action of IL-6 are far from clear. Modulation of insulin secretion by IL-6 does not seem to be a major factor; on the other hand, there is recent evidence that IL-6 may produce insulin resistance.^2-3 Cytokines can exert their effects either directly or indirectly, although a direct effect of IL-6 on the insulin–receptor transduction pathway has not been demonstrated. Indirect effects on insulin resistance have been attributed to the stimulatory action of IL-6 on the . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Aruna D. Pradhan, JoAnn E. Manson, Nader Rifai, Julie E. Buring, and Paul M. Ridker
JAMA. 2001;286(3):327-334.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Hepatosplanchnic clearance of interleukin-6 in humans during exercise
Febbraio et al.
Am. J. Physiol. Endocrinol. Metab. 2003;285:E397-E402.
ABSTRACT | FULL TEXT  

Type 2 diabetes as an inflammatory disorder
Sattar et al.
British Journal of Diabetes & Vascular Disease 2003;3:36-41.
ABSTRACT  

Is Metabolic Syndrome X an Inflammatory Condition?
Das
Exp. Biol. Med. 2002;227:989-997.
ABSTRACT | FULL TEXT  

Muscle-derived interleukin-6: mechanisms for activation and possible biological roles
FEBBRAIO and PEDERSEN
FASEB J. 2002;16:1335-1347.
ABSTRACT | FULL TEXT